1. Home
  2. SVV vs IVA Comparison

SVV vs IVA Comparison

Compare SVV & IVA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Savers Value Village Inc.

SVV

Savers Value Village Inc.

HOLD

Current Price

$7.45

Market Cap

1.4B

ML Signal

HOLD

Logo Inventiva S.A. American Depository Shares

IVA

Inventiva S.A. American Depository Shares

HOLD

Current Price

$5.55

Market Cap

1.4B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
SVV
IVA
Founded
1954
2011
Country
United States
France
Employees
N/A
84
Industry
Other Specialty Stores
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.4B
1.4B
IPO Year
2021
N/A

Fundamental Metrics

Financial Performance
Metric
SVV
IVA
Price
$7.45
$5.55
Analyst Decision
Buy
Strong Buy
Analyst Count
7
11
Target Price
$13.67
$15.91
AVG Volume (30 Days)
1.1M
237.2K
Earning Date
04-30-2026
03-30-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
0.14
N/A
Revenue
$1,678,954,000.00
N/A
Revenue This Year
$6.91
N/A
Revenue Next Year
$7.58
N/A
P/E Ratio
$51.57
N/A
Revenue Growth
9.19
N/A
52 Week Low
$6.68
$2.90
52 Week High
$13.89
$7.98

Technical Indicators

Market Signals
Indicator
SVV
IVA
Relative Strength Index (RSI) 33.82 38.81
Support Level N/A $5.15
Resistance Level $11.03 $5.78
Average True Range (ATR) 0.36 0.31
MACD 0.00 -0.07
Stochastic Oscillator 38.21 27.78

Price Performance

Historical Comparison
SVV
IVA

About SVV Savers Value Village Inc.

Savers Value Village Inc is a for-profit thrift operator in the United States and Canada. It purchases second-hand textiles (i.e., clothing, bedding, and bath items), shoes, accessories, housewares, books, and other goods from its non-profit partners (NPPs), either directly from them or via on-site donations (OSDs) at Community Donation Centers at its stores. The company then processes, selects, prices, and sells these items in its stores.

About IVA Inventiva S.A. American Depository Shares

Inventiva SA is a France-based biopharmaceutical company specialized in developing drugs that impact on nuclear receptors, transcription factors and epigenetic modulation. The company is focused on developing its product candidate, lanifibranor, for the treatment of patients with non-alcoholic steatohepatitis, or NASH, a disease for which there are currently no approved therapies. The company is also involved in developing a portfolio of pre-clinical therapy programs. It operates in the segment of Service delivery and clinical stage research, notably into therapies in the areas of oncology, fibrosis, and rare diseases. All the company's operations are in France. Majority of the group's revenue is derived from its research partnerships with AbbVie and BI.

Share on Social Networks: